2-Methyl-5-(5-methyl-benzooxazol-2-yl)-phenylamine, 100mg

SB297006, 50mg

1-(4-Fluoro-phenyl)-3-phenyl-1H-pyrazole-5-carboxylic acid, 98.0%, 5g

(S)-2-((tert-Butoxycarbonyl)amino)-4-methoxybutanoic acid, 95+%, 1g

5-Bromo-1,2,3,4-tetrahydro-1,7-naphthyridine, 95+%, 250mg

Cryogenic box ROTILABO® cardboard 133 x 133 mm with waterproof plastic coating, red, 10 Piece(s)

2,6-Bis[(2-hydroxyethyl)amino]toluene>98.0%(GC)(T)5g

GC capillary column ROTI®Cap-1701 MS, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

4-(Trifluoromethyl)-2,3-dihydro-1H-inden-1-amine hydrochloride, 97.0%, 1g

Fmoc-Dab.HCl, 99.0%, 10g

Methyl 5-chloro-2-(chlorosulfonyl)benzoate, 95+%, 250mg

6-((4-(Aminomethyl)benzyl)oxy)-7H-purin-2-amine, 95.0%, 5g

11-Bromoundecanoic Acid>97.0%(GC)(T)500g